1.Sarfati D, Hill S, Blakely T, Robson B, Purdie G, Dennett E, et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC cancer. 2009;9:116.
2.Munro AJ, Bentley AH. Deprivation, comorbidity and survival in a cohort of patients with colorectal cancer. European journal of cancer care. 2004;13(3):254–62.
3.Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35(3):181–200.
4.Extermann M. Measuring comorbidity in older cancer patients. European journal of cancer (Oxford, England: 1990). 2000;36(4):453–71.
5.Sarfati D, Gurney J, Lim B, Bagheri N, Simpson A, Koea J, et al. Identifying important comorbidity among cancer populations using administrative data: prevalence and impact on survival. Asia-Pacific Journal of Clinical Oncology. 2013;doi: 10.1111/ajco.12130.
6.Sarfati D, Gurney J, Stanley J, salmond C, Crampton P, Dennett E, et al. Cancer-specific administrative data-based comorbidity indices provided valid alternative to Charlson and NHI indices. Journal of Clinical Oncology. 2014;67(5):586–95.
7.Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337–50.
8.Sogaard M, Thomsen RW, Bossen KS, Sorensen HT, Norgaard M. The impact of comorbidity on cancer survival: a review. Clinical epidemiology. 2013;5(Suppl 1):3–29.
9.Institute of Medicine. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: The National Academies Press.; 2013.
10.Sarfati D, Gurney J, Stanley J, Koea J. A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes. BMC cancer. 2014;14:821.
11.Boakye D, Rillmann B, Walter V, Jansen L, Hoffmeister M, Brenner H. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: A systematic review and meta-analysis. Cancer Treatment Reviews. 2018;64:30–9.
12.Brewer N, Borman B, Sarfati D, Jeffreys M, Fleming ST, Cheng S, et al. Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study. BMC cancer. 2011;11:132.
13.Lee L, Cheung WY, Atkinson E, Krzyzanowska MK. Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol. 2011;29(1):106–17.
14.Chaudhary RK, Bhaduri D, Bhatia M, Hatti S, Ba R, Meva J. Influence of comorbidity in cancer surgery on treatment decisions, postoperative course and oncological outcome. Asia-Pacific Journal of Clinical Oncology. 2013;9(1):47–52.
15.Iachina M, Green A, Jakobsen E. The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open. 2014;4(2):e003846.
16.Kaerlev L, Iachina M, Trosko O, Qvist N, Ljungdalh PM, Nørgård BM. Colon cancer patients with a serious psychiatric disorder present with a more advanced cancer stage and receive less adjuvant chemotherapy - A Nationwide Danish Cohort Study. BMC cancer. 2018;18(1):1050.
17.Seigneurin A, Delafosse P, Trétarre B, Woronoff AS, Velten M, Grosclaude P, et al. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries. BMC cancer. 2018;18(1):1091.
18.Tetsche MS, Dethlefsen C, Pedersen L, Sorensen HT, Norgaard M. The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort study. BMC cancer. 2008;8(1):31.
19.Bradley CJ, Dahman B, Anscher M. Prostate cancer treatment and survival: evidence for men with prevalent comorbid conditions. Med Care. 2014;52(6):482–9.
20.Grann AF, Froslev T, Olesen AB, Schmidt H, Lash TL. The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987–2009: a registry-based cohort study. Br J Cancer. 2013;109(1):265–71.
21.Gross CP, McAvay GJ, Guo Z, Tinetti ME. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer. 2007;109(12):2410–9.
22.Jehn CF, Boning L, Kroning H, Pezzutto A, Luftner D. Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer. European journal of cancer (Oxford, England: 1990). 2014;50(7):1269–75.
23.Puts MT, Hardt J, Monette J, Girre V, Springall E, Alibhai SM. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst. 2012;104(15):1133–63.
24.Puts MT, Santos B, Hardt J, Monette J, Girre V, Atenafu EG, et al. An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol. 2014;25(2):307–15.
25.Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. Journal of Clinical Oncology. 2014;32(24):2595–603.
26.Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. Journal of Clinical Oncology. 2007;25(14):1824–31.
27.Ramjaun A, Nassif MO, Krotneva S, Huang AR, Meguerditchian AN. Improved targeting of cancer care for older patients: a systematic review of the utility of comprehensive geriatric assessment. J Geriatr Oncol. 2013;4(3):271–81.
28.Yokom DW, Alibhai SMH, Sattar S, Krzyzanowska MK, Puts MTE. Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer. J Geriatr Oncol. 2018.
29.Kalsi T, Babic-Illman G, Ross P, Maisey N, Hughes S, Fields P, et al. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. British Journal of Cancer. 2015;112:1435–44.
30.McCorkle R, Strumpf NE, Nuamah IF, Adler DC, Cooley ME, Jepson C, et al. A specialized home care intervention improves survival among older post-surgical cancer patients. J Am Geriatr Soc. 2000;48(12):1707–13.
31.Rao AV, Hsieh F, Feussner JR, Cohen HJ. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci. 2005;60(6):798–803.
32.Soejono C. The role of comprehensive geriatric assessment (CGA) in the management of stage 3 hepatocellular carcinoma in the elderly. Crit Rev Oncol Hematol. 2006;60:S20.
33.Ministry of Health. Content Guide 2014/15: New Zealand Health Survey. Wellington: Ministry of Health; 2015.
34.EORTC: Quality of Life Group. QLQ-C30: Quality of Life Cancer Patients [
35.Small W, Pugh S, Wagner L, Kirshner J, Sidhu K, Bury M, et al. RTOG 0841: Two-Item Questionnaire Effectively Screens for Depression in Cancer Patients Receiving Radiation Therapy. International Journal of Radiation Oncology • Biology • Physics. 2013;87(2):S2.
36.Mitchell AJ. Are one or two simple questions sufficient to detect depression in cancer and palliative care? A Bayesian meta-analysis. British journal of cancer. 2008;98(12):1934–43.
37.Lexi-comp online user guide [Internet]. 2012. Available from: http://www.wolterskluwercdi.com/lexicomp-online/.
38.U.S.Department of Health and Human Service. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. National Cancer Institute; 2010.
39.Freyer G, Geay JF, Touzet S, Provencal J, Weber B, Jacquin JP, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol. 2005;16(11):1795–800.
40.Barratt H, Campbell M, Moore L, Zwarenstein M, Bower P. Essay 2. Randomised controlled trials of complex interventions and large-scale transformation of services. In: Raine R, Fitzpatrick R, Barratt H, al. e, editors. Challenges, solutions and future directions in the evaluation of service innovations in health care and public health. 4. Southampton (UK): NIHR Journals Library; 2016
41.Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. The Lancet Oncology. 2012;13(10):e437–44.
42.Hernandez Torres C, Hsu T. Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review. European urology focus. 2017;3(4–5):330–9.
43.Bellera CA, Rainfray M, Mathoulin-Pélissier S, Mertens C, Delva F, Fonck M, et al. Screening older cancer patients: first evaluation of the G–8 geriatric screening tool. Ann Oncol. 2012;23(8):2166–72.
44.Kalsi T, Babic-Illman G, Hughes S, Ross P, Fields P, Brodie H, et al. Validity and reliability of a comprehensive geriatric assessment screening questionnaire (CGA-GOLD) in older people with cancer. Age and Ageing. 2014;43(suppl_1):Pages i30.
45.Perfors IAA, May AM, Boeijen JA, de Wit NJ, van der Wall E, Helsper CW. Involving the general practitioner during curative cancer treatment: a systematic review of health care interventions. BMJ Open. 2019;9(4):e026383.
46.Meyer J. Using qualitative methods in health related action research. British Medical Journal. 2000;320:178–81.
47.Waterman H, Tillen D, Dickson R, de Koning K. Action Research: a systematic review and guidance for assessment: Full Report. Health Technology Assessment [Internet]. 2001 April 4 2008; 5(23). Available from: http://www.hta.ac.uk/execsumm/summ523.shtml.
48.Williamson G, Posser S. Action Research: politics, ethics and participation. Journal of Advanced Nursing. 2002;40(5):587–93.
49.Holtrop JS, Rabin BA, Glasgow RE. Dissemination and Implementation Science in Primary Care Research and Practice: Contributions and Opportunities. The Journal of the American Board of Family Medicine. 2018;31(3):466–78.
50.Mitchell SA, Chambers DA. Leveraging Implementation Science to Improve Cancer Care Delivery and Patient Outcomes. Journal of oncology practice. 2017;13(8):523–9.
51.Boyd H, McKernon S, Mullin B, Old A. Improving healthcare through the use of co-design. New Zealand Medical Journal. 2012;125(1357).
52.Eyles H, Jull A, Dobson R, Firestone R, Whittaker R, Te Morenga L, et al. Co-design of mhealth delivered interventions: A systematic review to assess key methods and processes. Current Nutrition Reports. 2016;5(3):8.
53.Cargo M, Mercer SL. The value and challenges of participatory research: strengthening its practice. Annual review of public health. 2008;29:325–50.